OncBioMune’s Experimental Chemo Shows Potential to Inhibit Growth of Drug-resistant OC Cells
News
PGT, an experimental chemotherapy developed by OncBioMune, inhibited the growth of ovarian cancer cells resistant to multiple chemotherapeutic agents. These preliminary results suggest that the therapy could potentially be used ... Read more